Package 70000-0717-1

{"route": ["OPHTHALMIC"], "spl_id": "32bff197-0006-d853-e063-6394a90a8cc2", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111339"], "spl_set_id": ["d91a3512-b87b-4950-b41d-8d094c0e2c38"], "manufacturer_name": ["CARDINAL HEALTH"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (70000-0717-1)  / 5 mL in 1 BOTTLE", "package_ndc": "70000-0717-1", "marketing_start_date": "20250415"}], "brand_name": "Leader Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "70000-0717_32bff197-0006-d853-e063-6394a90a8cc2", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "70000-0717", "generic_name": "Olopatadine Hydrochloride Ophthalmic Solution", "labeler_name": "CARDINAL HEALTH", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Leader Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA206046", "marketing_category": "ANDA", "marketing_start_date": "20250415", "listing_expiration_date": "20261231"}